학술논문

Brigatinib (BRG) vs crizotinib (CRZ) in anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor-naive ALK plus non-small cell lung cancer (NSCLC): ALTA-1L final results
Document Type
Journal
Source
ANNALS OF ONCOLOGY; APR 2022, 33 pS44-pS45, 2p. Supplement: 2
Subject
Language
English
ISSN
15698041